SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001723128-19-000079
Filing Date
2019-05-09
Accepted
2019-05-09 16:16:50
Documents
88
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q amrx-03x31x201910qdoc.htm 10-Q 1131163
2 EXHIBIT 31.1 amrx-03x31x2019xex311stewa.htm EX-31.1 16419
3 EXHIBIT 31.2 amrx-03x31x2019xex312brann.htm EX-31.2 17105
4 EXHIBIT 32.1 amrx-03x31x2019xex321stewa.htm EX-32.1 8604
5 EXHIBIT 32.2 amrx-03x31x2019xex322brann.htm EX-32.2 9189
  Complete submission text file 0001723128-19-000079.txt   8260115

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT amrx-20190331.xml EX-101.INS 1758501
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amrx-20190331.xsd EX-101.SCH 70350
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT amrx-20190331_cal.xml EX-101.CAL 139682
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amrx-20190331_def.xml EX-101.DEF 376963
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amrx-20190331_lab.xml EX-101.LAB 877006
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amrx-20190331_pre.xml EX-101.PRE 527290
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38485 | Film No.: 19810769
SIC: 2834 Pharmaceutical Preparations